Skip Navigation



Rheumatology Advance Access published online on May 9, 2008
Rheumatology, doi:10.1093/rheumatology/ken188
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/7/1103    most recent
ken188v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Evans, S. J.
Right arrow Articles by O'Sullivan, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, S. J.
Right arrow Articles by O'Sullivan, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Reversible Hodgkin's lymphoma associated with Epstein–Barr virus occurring during azathioprine therapy for SLE

S. J. Evans1, D. K. Watson2 and M. O'Sullivan1

1Department of Rheumatology and 2Department of Haematology, Wrexham Maelor Hospital, North East Wales NHS Trust, Wrexham, UK

Correspondence to: J. Evans, Rheumatology Department, Wrexham Maelor Hospital, Croesnewydd Road, Wrexham, LL13 7TD, UK. E-mail: jayneevans@tesco.net

The first 10% of the full text of this article appears below.

SIR, We report the case of a 47-yr-old Caucasian female with a 20-yr history of SLE who had been treated with AZA, cyclosporin and prednisolone in 1998 for lupus pneumonitis. From 2005, AZA had been continued at a dose . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?